Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
roche
2
×
biopharma
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
companion diagnostic
deals
detroit blog main
detroit top stories
dna sequencing
drugs
duchenne
entrectinib
europe blog main
europe top stories
express scripts
fda
foundation medicine
indiana blog main
indiana top stories
josh bilenker
keytruda
larotrectinib
licensing
loxo oncology
m&a
melanie nallicheri
merck
muscular dystrophy
national
new england journal of medicine
What
fda
2
×
medicine
second
2
×
approval
approved
betting
billion
biopharma
cancer
deal
deeper
dna
drug
duchenne
fingerprint
gene
genetic
going
historic
matter
nd
new
oks
puts
recently
rna
roche
sarepta
swiss
targets
therapeutics
therapy
time
tissues
tumor's
won
world
Language
unset
Current search:
roche
×
fda
×
second
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
